OpenAI's Miles Wang Is Building a $2B AI Drug Discovery Startup — Here's What Solo Builders Should Watch
🎧 Prefer to listen? Your browser does not support the audio element. Miles Wang, a researcher at OpenAI who dropped out of Harvard to work on AI-powered biological discovery, is reportedly in talks to launch his own startup — at a $2 billion valuation. Lightspeed Venture Partners is considering leading a $200 million round. And several other OpenAI researchers are expected to follow him out the door. ...